Back

Genotype and Clinical Characteristics of Patients with Wolfram Syndrome and WFS1-related Disorders

Palaniappan, N.; Brown, C.; An, W.; Campbell, T.; Hurst, S.; Urano, F.; Hershey, T.; Lee, E.; Verma, M.; Pope, E.; Lee, S.; Blacher, L.; Neerumalla, P.; Marshall, B.; Lopez de Heredia, M.; Martinez, V.

2023-02-16 genetic and genomic medicine
10.1101/2023.02.15.23284904 medRxiv
Show abstract

ObjectiveWolfram syndrome (WFS) is an autosomal recessive disorder associated with juvenile-onset diabetes mellitus, optic atrophy, diabetes insipidus, and sensorineural hearing loss. We sought to elucidate the relationship between genotypic and phenotypic presentations of Wolfram syndrome which would assist clinicians in classifying the severity and prognosis of Wolfram syndrome more accurately. ApproachPatient data from the Washington University International Registry and Clinical Study for Wolfram Syndrome and patient case reports were analyzed to select for patients with two recessive mutations in the WFS1 gene. Mutations were classified as being either nonsense/frameshift variants or missense/in-frame insertion/deletion variants and statistical analysis was performed using unpaired and paired t-tests and one- and two-way ANOVA with Tukeys or Dunnetts tests. ResultsA greater number of genotype variants correlated with earlier onset and a more severe presentation of Wolfram syndrome. Secondly, non-sense and frameshift variants had more severe phenotypic presentations than missense variants, as evidenced by optic atrophy emerging significantly earlier in patients with 2 nonsense/frameshift alleles compared with 0 missense transmembrane variants. In addition, the number of transmembrane in-frame variants demonstrated a statistically significant dose-effect on age of onset of diabetes mellitus and optic atrophy. Summary / ConclusionsThe results contribute to our current understanding of the genotype-phenotype relationship of Wolfram syndrome, suggesting that alterations in coding sequences result in significant changes in the presentation and severity of Wolfram. The impact of these findings is significant, as the results will aid clinicians in predicting more accurate prognoses and pave the way for personalized treatments for Wolfram syndrome.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.1%
33.7%
2
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.1%
10.3%
3
PLOS ONE
4510 papers in training set
Top 21%
8.6%
50% of probability mass above
4
Genetics in Medicine
69 papers in training set
Top 0.3%
6.5%
5
Human Mutation
29 papers in training set
Top 0.2%
3.7%
6
Journal of Medical Genetics
28 papers in training set
Top 0.1%
3.7%
7
Scientific Reports
3102 papers in training set
Top 40%
3.3%
8
Frontiers in Neurology
91 papers in training set
Top 2%
2.1%
9
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.5%
1.9%
10
Cureus
67 papers in training set
Top 3%
1.7%
11
Human Molecular Genetics
130 papers in training set
Top 3%
1.0%
12
Frontiers in Human Neuroscience
67 papers in training set
Top 2%
1.0%
13
Translational Vision Science & Technology
35 papers in training set
Top 0.5%
0.9%
14
Frontiers in Genetics
197 papers in training set
Top 8%
0.9%
15
Frontiers in Neuroscience
223 papers in training set
Top 7%
0.8%
16
Muscle & Nerve
10 papers in training set
Top 0.3%
0.8%
17
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
18
Genes
126 papers in training set
Top 3%
0.8%
19
npj Genomic Medicine
33 papers in training set
Top 0.9%
0.8%
20
European Journal of Human Genetics
49 papers in training set
Top 1%
0.7%
21
Brain and Behavior
37 papers in training set
Top 2%
0.7%
22
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.7%
0.7%
23
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
0.7%
24
Frontiers in Aging Neuroscience
67 papers in training set
Top 4%
0.7%
25
Neurobiology of Disease
134 papers in training set
Top 5%
0.5%